Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Healthcare Breadcrumb chevron Pharmaceuticals Breadcrumb chevron Zim Laboratories
Zim Laboratories logo

541400 - Zim Laboratories Share News

₹90.15 1.9  2.1%

Last Trade - 17/05/21

Sector
Healthcare
RiskRating
Highly Speculative
Size
Micro Cap
Style
Contrarian
Market Cap £14.2m
Enterprise Value £21.1m
Revenue £29.3m
Position in Universe 1611th / 3112
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions 541400 Dividends
All News
All News Reuters News Company Announcements
BRIEF-India's Zim Laboratories Dec-Quarter Consol PAT Falls
11th Feb News
BRIEF-Zim Laboratories Ltd Dec Quarter Consol PAT Falls
11th Feb News
BRIEF-India's Zim Laboratories Posts Sept-Quarter Consol Profit
26th Oct '20 News
BRIEF-Zim Laboratories Signs Pact With Brazil's Hypera Pharma
19th Aug '20 News
BRIEF-India's Zim Laboratories June-Qtr Consol PAT Rises
4th Aug '20 News
BRIEF-Zim Laboratories Ltd - Filed Regulatory Dossier For Approval Of Rizatriptan Orally Dissolving Film In Europe
7th Jul '20 News
BUZZ-India's Zim Laboratories hits near 2-month high on new U.S. patent issue
9th Jun '20 News
BRIEF-Zim Laboratories Gets U.S. Patent For Invention
8th Jun '20 News
BRIEF-Zim Laboratories March-Quarter Consol Profit Flat
2nd Jun '20 News
BRIEF-Zim Laboratories Ltd - Developed Hand Sanitizer With Anti-Viral Activity, Filed Patent
20th Mar '20 News
BRIEF-India's Zim Laboratories June Qtr PAT falls
6th Aug '19 News
BRIEF-Zim Laboratories March-Qtr PAT Falls
22nd May '19 News
BRIEF-Zim Laboratories Approves Appointment Of Shyam Mohan Patro As CFO
22nd Feb '19 News
BRIEF-India's Zim Laboratories Dec Qtr Consol PAT Falls
6th Feb '19 News
BRIEF-India's Zim Laboratories June Qtr PAT Rises
14th Aug '18 News
BRIEF-Zim Laboratories To Consider Issue Of Bonus Shares
10th Aug '18 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.